Good morning. Elizabeth Cooney here at STAT HQ in Boston, pinch-hitting for Ed Silverman, who would no doubt remind you we have survived until the middle of the week. Not sure that resonates with Ed and others at the swirling conference called J.P. Morgan in San Francisco, but that, too, shall pass. We have lots of news to share in the meantime.
Democrats heaped criticism on pharma during Tuesday’s debate, highlighting a long list of policies they say will help lower high drug prices, STAT reports. Sen. Elizabeth Warren (D-Mass.), in particular, doubled down on a pledge to lower drug prices on her first day as president, using executive action to make it easier for generic drug makers to move in on brand-name drugs that were created using federally funded research.